DAX-1 and the adrenal cortex

Current Opinion in Endocrinology and Diabetes

Volumn 6, Issue 3, 1999, Pages 185-190

  Lalli, Enzo ^a   Sassone Corsi, Paolo ^a  

^a INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HORMONE RECEPTOR; STEROID HORMONE; STEROIDOGENIC FACTOR 1;

ADRENAL CORTEX; ADRENAL CORTEX DISEASE; ADRENAL INSUFFICIENCY; ANIMAL CELL; ARTICLE; CLINICAL FEATURE; GENE CONTROL; GENE FUNCTION; GENE MUTATION; GENE STRUCTURE; HORMONE SYNTHESIS; MISSENSE MUTATION; MOUSE; NONHUMAN;

EID: 0033056625     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-199906000-00003     Document Type: Article

References (44)

1. Mesiano S, Jaffe RB: Developmental and functional biology of the primate fetal adrenal cortex. Endocr Rev 1997, 18:378-403.
2. Dunn TB: Normal and pathologic anatomy of the adrenal gland of the mouse, including neoplasms. J Natl Cancer Inst 1970, 44:1323-1389.
3. MIM 300200: http://www.ncbi.nlm.nih.gov/omim.
4. Kletter GB, Gorski JL, Kelch RP: Congenital adrenal hypoplasia and isolated gonadotropin deficiency. Trends Endocrinol Metab 1991, 2:123-128.
5. Habiby RL, Boepple P, Nachtigall L, Sluss PM, Crowley WF Jr, Jameson JL: Adrenal hypoplasia congenita with hypogonadotropic hypogonadism. Evidence that DAX-1 mutations lead to combined hypothalamic and pituitary defects in gonadotropin production. J Clin Invest 1996, 98:1055-1062. The clinical variability of HHG associated with AHC is exemplified by this case report of two patients. Measurement of circulating LH, follicle-stimulating hormone, and free glycoprotein hormone α-subunit together with a study of response to the administration of pulsatile GnRH indicate that HHG associated with AHC is caused by combined hypothalamic failure in GnRH release and pituitary detect in gonadotropin production.
6. Takahashi T, Shoji Y, Shoji Y, Haraguchi N, Takahashi I, Takada G: Active hypothalamic-pituitary-gonadal axis in an infant with X-linked adrenal hypoplasia congenita. J Pediatr 1997, 130:485-488.
7. Kaiserman KB, Nakamoto JM, Geffner ME, McCabe ERB: Minipuberty of infancy and adolescent pubertal function in adrenal hypoplasia congenital. J Pediatr 1998, 133:300-302.
8. Peter M, Viemann M, Partsch CJ, Sippell WG: Congenital adrenal hypoplasia: Clinical spectrum, experience with hormonal diagnosis, and report on new point mutations of the DAX-1 gene. J Clin Endocrinol Metab 1998, 83:2666-2674.
9. Patil SR, Bartley JA, Murray JC, Ionasescu VV, Pearson PL: X-linked glycerol kinase deficiency, adrenal hypoplasia and myopathy maps at Xp21. Cytogenet Cell Genet 1985, 40:720-721.
10. Zanaria E, Muscatelli F, Bardoni B, Strom TM, Guioli S, Guo W, et al.: An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature 1994, 372:635-641.
11. Muscatelli F, Strom TM, Walker AP, Zanaria E, Récau O, Meindl A, et al.: Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature 1994, 372:672-676.
12. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schütz G, Umesono K, et al.: The nuclear receptor superfamily: The second decade. Cell 1995, 83:835-839.
13. Ikeda Y, Swain A, Weber TJ, Hentges KE, Zanaria E, Lalli E, et al.: Steroidogenic factor 1 and Dax-1 colocalize in multiple cell lineages: Potential links in endocrine development. Mol Endocrinol 1996, 10:1261-1272.
14. Tamai KT, Monaco L, Alastalo TP, Lalli E, Parvinen M, Sassone-Corsi P: Hormonal and developmental regulation of DAX-1 expression in Sertoli cells. Mol Endocrinol 1996, 10:1561-1569.
15. Bardoni B, Zanaria E, Guioli S, Floridia G, Worley KC, Tonini G, et al.: A dosage sensitive locus at chromosome Xp21 is involved in male to female sex reversal. Nat Genet 1994, 7:497-501.
16. Swain A, Narvaez V, Burgoyne P, Camerino G, Lovell-Badge R: Dax1 antagonizes Sry action in mammalian sex determination. Nature 1998, 391:761-767.
17. Greenfield A: Genes, cells and organs: Recent developments in the molecular genetics of mammalian sex determination. Mamm Genome 1998, 9:683-687.
18. Wurtz J-M, Bourguet W, Renaud J-P, Vivat V, Chambon P, Moras D, Gronemeyer H: A canonical structure for the ligand-binding domain of nuclear receptors. Nat Struct Nat Struc Biol 1996, 3:87-94.
19. Lalli E, Bardoni B, Zazopoulos E, Wurtz J-M, Strom TM, Moras D, SassoneCorsi P: A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenita. Mol Endocrinol 1997, 11:1950-1960. A structural model of the DAX-1 protein C-terminus is presented on the basis of the similarity with apo-RXRα and holo-RARτ. Deletion analysis shows that the DAX-1 C-terminus contains a powerful cell type- and promoter-specific transcriptional silencing domain that needs two cooperating subdomains to function. One of these subdomains is located within helix H3, and the other is within helix H12. All mutations found in AHC kindreds impair transcriptional silencing by DAX-1.
20. Zhang Y-H, Guo W, Wagner RL, Huang B-L, McCabe L, Vilain E, et al.: DAX1 mutations map to putative structural domains in a deduced three-dimensional model. Am J Hum Genet 1998, 62:855-864. This article includes a comprehensive list of all DAX-1 mutations found to date in patients with AHC. All seven single amino acid changes identified map to the C-terminal portion of the DAX-1 protein, in the conserved hydrophobic core of the structure.
21. Danielan PS, White R, Lees JA, Parker MG: Identification of a conserved region required for hormone-dependent transcriptional activation by steroid hormone receptors. EMBO J 1992, 11:1025-1033.
22. Durand B, Saunders M, Gaudon C, Roy B, Losson R, Chambon P: Activation function 2 (AF-2) of retinoic acid receptor and 9-cis retinoic acid receptor: presence of a conserved autonomous constitutive activating domain and influence of the nature of the response element on AF-2 activity. EMBO J 1994, 13:5370-5382.
23. Ito M, Yu R, Jameson JL: DAX-1 inhibits SF-1-mediated transactivation via a carboxy-terminal domain that is deleted in adrenal hypoplasia congenita. Mol Cell Biol 1997, 17:1476-1483. DAX-1 is found to specifically inhibit SF-1-mediated transactivation and to interact with SF-1 in vitro in a pull-down assay but not in the gel-mobility assay. A transcriptional silencing domain is shown to exist in the DAX-1 protein, the function of which is impaired by mutations found in patients with AHC.
24. Licht JD, Grossel MJ, Figge J, Hansen UM: Drosophila Krüppel protein is a transcriptional repressor. Nature 1990, 346:76-79.
25. White KP, Hurban P, Watanabe T, Hogness DS: Coordination of Drosophila metamorphosis by two ecdysone-induced nuclear receptors. Science 1997, 276:114-117.
26. Madden SL, Cook DM, Morris JF, Gashler A, Sukhatme VP, Rauscher FJ 3d: Transcriptional repression mediated by WT1, the Wilms tumor gene product. Science 1991, 253:1550-1553.
27. Baniahmad A, Köhne AC, Renkawitz RA: A transferable silencing domain is present in the thyroid hormone receptor, in the v-erbA oncogene product and in the retinoic acid receptor. EMBO J 1992, 11:1015-1023.
28. Catron KM, Zhang H, Marshall SC, Inostreza JA, Wilson JM, Abate C: Transcriptional repression by Msx-1 does not require homeodomain DNA-binding sites. Mol Cell Biol 1995, 15:861-871.
29. Stocco DM, Clark BJ: Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev 1996, 17:221-244.
30. Parker KL, Schimmer BP: Steroidogenic factor 1: A key determinant of endocrine development and function. Endocr Rev 1997, 18:361-377.
31. Nachtigal MW, Hirokawa Y, Enyeart-VanHouten DL, Flanagan JN, Hammer CD, Ingraham HA: Wilms' tumor 1 and Dax-1 modulate the orphan nuclear receptor SF-1 in sex-specific gene expression. Cell 1998, 93:445-454. This article shows that WT1-KTS isoforms associate and synergize with SF-1 in transactivating the Müllerian inhibiting substance promoter. WT1 missense mutations found in the Denys-Drash syndrome that produce mate pseudohermaphroditism impair transcriptional synergism with SF-1. DAX-1 is shown to antagonize the synergy between SF-1 and WT1 and to associate directly with SF-1 in the yeast two-hybrid system.
32. Crawford PA, Dorn C, Sadovsky Y, Millbrandt J: Nuclear receptor DAX-1 recruits nuclear receptor corepressor N-CoR to steroidogenic factor 1. Mol Cell Biol 1998, 18:2949-2956. DAX-1 is shown to interact with SF-1 in a mammalian two-hybrid system. DAX-1 mutations R267P and, ΔV269, found in patients with AHC, significantly impair this interaction. Amino acids 226-230 and 437-447 of SF-1 are required for interaction with DAX-1. In addition, wild-type DAX-1 but not DAX-1 and ΔV269 DAX-1, can recruit the corepressor N-CoR to SF-1. The other corepressor, SMRT, cannot interact with DAX-1 in this assay. A point mutation in DAX-1 (F449D) is identified on the basis of sequence similarity with the orphan nuclear receptor Rev-Erb (which also interacts with N-CoR), which impairs its repression activity and interaction with N.CoR.
33. Torchia J, Glass C, Rosenfeld MG: Co-activators and CO-repressers in the integration of transcriptional responses. Curr Opin Cell Biol 1998, 10:373-383.
34. Chen JD, Evans RM: A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 1995, 377:454-457.
35. Zazopoulos E, Lalli E, Stocco DM, Sassone-Corsi P: DNA binding and transcriptional repression by DAX-1 blocks steroidogenesis. Nature 1997, 390:311-315. The DAX-1 protein is shown to bind to DNA stem-loop structures in vitro. DNA binding presents only loose sequence requirements and involves interaction with the DNA minor groove. Stem-loop structures are present in both the dax-1 and StAR promoters, which are essential for transcriptional repression by DAX-1. Block of StAR gene expression by DAX-1 in stably transfected Y-1 cells blocks steroid synthesis.
36. Lin D, Sugawara T, Strauss JF 3d, Clark BJ, Stocco DM, Saenger P, et al.: Role of steroidogenic acute regulatory protein in adrenal and gonadal steroidogenesis. Science 1995, 267:1828-1831.
37. Yu RN, Ito M, Jameson JL: The murine Dax-1 promoter is stimulated by SF-1 and inhibited by COUP-TF via a composite nuclear receptor-regulatory element. Mol Endocrinol 1998, 12:1010-1022.
38. Lalli E, Melner MH, Stocco DM, Sassone-Corsi P: DAX-1 blocks steroid production at multiple levels. Endocrinology 1998, 139:4237-4243.Experiments conducted using a hydroxylated cholesterol derivative show that, in addition to StAR DAX-1 inhibits the synthesis of P450scc and (through an indirect mechanism} 3β-HSD in stably transfected Y-1 cells.
39. Reincke M, Beuschlein F, Lalli E, Arlt W, Vay S, Sassone-Corsi P, Allolio B: DAX-1 expression in human adrenocortical neoplasms: Implications for steroidogenesis. J Clin Endocrinol Metab 1998, 83:2597-2600.
40. Yu RN, Ito M, Saunders TL, Camper SA, Jameson JL: Role of Ahch in gonadal development and gametogenesis. Nat Genet 1998, 20:353-357. These authors inactivated the Dax-1 gene in mice with the Cre-lox strategy, crossing cytomegalovirus-promoter Cre transgenic mice with mice carrying a IoxP-targeted allele. Male mice whose single DAX-1 allele was inactivated were apparently normal. The only anomaly in their adrenal cortex was failure in regression of the X zone after puberty. In addition, expression of pituitary LHβ, follicle-stimulating hormone-β, glycoprotein hormone α-subunit, and adrenocorticotropic hormone was normal, as were levels of circulating LH, follicle-stimulating hormone, and corticosterone. Testis weight decreased by approximately 50%. At 10 weeks of age, the seminiferous tubules showed clear signs of epithelial degeneration; at 14 weeks of age, complete loss of germ cells was observed. Leydig cell hyperplasia was present adjacent to degenerated tubules. Females that had both Dax-1 alleles inactivated were normally fertile and had only mild defects in follicle development.
41. Swain A, Zanaria E, Hacker A, Lovett-Badge R, Camerino G: Mouse Dax1 expression is consistent with a role in sex determination as well as in adrenal and hypothalamus function. Nat Genet 1996, 12:404-409.
42. Zanaria E, Bardoni B, Dabovic B, Calvari V, Fraccaro M, Zuffardi O, Camerino G: Xp duplications and sex reversal. Philos Trans R Soc Lond B Biol Sci 1995, 350:291-296.
43. Tsien JZ, Chen DF, Gerber D, Tom C, Mercer EH, Anderson DJ, et al.: Subregion- and cell type-restricted gene knockout in mouse brain. Cell 1996, 87:1317-1326.
44. Schwenk F, Kuhn R, Angrand PO, Rajewsky K, Stewart AF: Temporally and spatially regulated somatic mutagenesis in mice. Nucleic Acids Res 1998, 26:1427-1432.